PM8 Peer comparison - Other REE projects analysis, page-42

First 42 Last

Share
Profile

Follow
Process1

1,431 Posts.

267

27/02/19

09:56

Post #: 37582244
Share

Originally posted by PubLunchMan: ↑

NdPr is my pick as the next commodity runner which could have a similar bull market effect like lithium had on associated stocks in recent years:

Rare earth neodymium (Nd) and praseodymium (Pr) forecast to be in deficit from 2019/20

"Rare earths are a collection of seventeen chemical elements, and despite what the name says they are relatively plentiful in the earth’s crust. Because of their unique magnetic, luminescent, and electro chemical properties, these elements when alloyed with other materials help make many technologies perform with reduced weight, reduced emissions and energy consumption; or give them greater efficiency, performance, speed, durability and thermal stability. Two key rare earths used to make the most powerful magnets used in EVs are neodymium (Nd) and praseodymium (Pr)."

China starting to import

"By as early as 2021, China could be set to transition from a major NdPr producer to a net importer as it rapidly ramps up its magnet production capability and continues to stamp out polluting and unsustainable operations."

"About 85 percent of the world’s neodymium comes out of a few mines in China. One mine called Baotou in northern China has created a toxic lake and other environmental horrors."

How China raised the stakes for electric vehicles

And from PM8 recent presentation regarding NdPr pricing:

DYOR

Expand

NdPr & PM8: Significant Supply Shortages in NdPr: Estimates by leading industry observers expect this shortage to be in the range of ~20,000 - 30,000 tpa which is equivalent to current production levels. This will be further exacerbated by NdPr price.

PM8 Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

CHW

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 62 more messages in this thread...

First 42 Last

Add PM8 (ASX) to my watchlist

PM8 Peer comparison - Other REE projects analysis, page-42

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Cleo adds Royal Women's Hospital to its clinical trial for ovarian cancer diagnosis

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects